id.exposure	id.outcome	outcome	exposure	method	Q	Q_df	Q_pval
GCST90199628	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	3-methylhistidine levels	Inverse variance weighted	7.08404567808755	14	0.931423371218896
GCST90199628	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	3-methylhistidine levels	MR Egger	7.02500150786582	13	0.900858535106732
GCST90199636	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Kynurenine levels	Inverse variance weighted	16.4376639164859	13	0.226301392913061
GCST90199636	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Kynurenine levels	MR Egger	15.1679725592075	12	0.232378811318631
GCST90199647	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Theophylline levels	Inverse variance weighted	4.97819272944852	12	0.958703366881057
GCST90199647	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Theophylline levels	MR Egger	4.8877423484501	11	0.93648089459681
GCST90199649	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-stearoyl-2-arachidonoyl-GPI (18:0/20:4) levels	Inverse variance weighted	22.8364857199536	17	0.154650029572699
GCST90199649	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-stearoyl-2-arachidonoyl-GPI (18:0/20:4) levels	MR Egger	22.1781865625606	16	0.137530770898035
GCST90199666	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Palmitoylcarnitine levels (Metabolon platform)	Inverse variance weighted	29.9888915581373	16	0.0180598774353804
GCST90199666	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Palmitoylcarnitine levels (Metabolon platform)	MR Egger	29.9627829255085	15	0.0120564066540359
GCST90199672	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Oxalate (ethanedioate) levels	Inverse variance weighted	14.2914642532881	13	0.353642608732951
GCST90199672	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Oxalate (ethanedioate) levels	MR Egger	13.1651337128281	12	0.357153239795181
GCST90199684	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-linoleoylglycerol (18:2) levels	Inverse variance weighted	1.55214547970803	8	0.991807650114188
GCST90199684	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-linoleoylglycerol (18:2) levels	MR Egger	0.490732636355379	7	0.999479712134213
GCST90199732	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-stearoyl-gpc (18:0) levels	Inverse variance weighted	4.81397694116539	2	0.0900861836644797
GCST90199732	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-stearoyl-gpc (18:0) levels	MR Egger	4.69480332170335	1	0.0302539612732726
GCST90199772	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-stearoyl-GPE (18:0) levels	Inverse variance weighted	6.76341131478643	4	0.148931681841967
GCST90199772	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-stearoyl-GPE (18:0) levels	MR Egger	3.27030816034825	3	0.351796621757375
GCST90199780	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-stearoyl-GPG (18:0) levels	Inverse variance weighted	0.0126563778691104	3	0.999622745374256
GCST90199780	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-stearoyl-GPG (18:0) levels	MR Egger	1.54074395550979e-33	2	1
GCST90199789	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	2-palmitoyl-GPC (16:0) levels	Inverse variance weighted	3.94430452610506e-31	2	1
GCST90199831	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-stearoyl-2-oleoyl-GPE (18:0/18:1) levels	Inverse variance weighted	9.86076131526265e-32	2	1
GCST90199914	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Oleoyl-linoleoyl-glycerol (18:1/18:2) [2] levels	Inverse variance weighted	3.94430452610506e-31	2	1
GCST90199938	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	3-methyl catechol sulfate (1) levels	Inverse variance weighted	0.244349702609957	2	0.884993612685317
GCST90199938	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	3-methyl catechol sulfate (1) levels	MR Egger	7.70371977754894e-32	1	1
GCST90199962	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Acisoga levels	Inverse variance weighted	0.0485436198042525	2	0.976020381695724
GCST90199962	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Acisoga levels	MR Egger	1.97215226305253e-31	1	1
GCST90200005	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Citraconate/glutaconate levels	Inverse variance weighted	0.349686150079853	4	0.986385043933538
GCST90200005	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Citraconate/glutaconate levels	MR Egger	0.327767508060568	3	0.954724300484747
GCST90200039	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-stearoyl-2-linoleoyl-GPE (18:0/18:2) levels	Inverse variance weighted	3.94430452610506e-31	2	1
GCST90200041	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-palmitoyl-2-stearoyl-gpc (16:0/18:0) levels	Inverse variance weighted	0.72811468509277	3	0.86657200586335
GCST90200041	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-palmitoyl-2-stearoyl-gpc (16:0/18:0) levels	MR Egger	9.86076131526265e-32	2	1
GCST90200043	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-palmitoyl-2-docosahexaenoyl-gpc (16:0/22:6) levels	Inverse variance weighted	9.86076131526265e-32	2	1
GCST90200045	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-stearoyl-2-arachidonoyl-GPE (18:0/20:4) levels	Inverse variance weighted	7.02697917554168	4	0.134469349734364
GCST90200045	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-stearoyl-2-arachidonoyl-GPE (18:0/20:4) levels	MR Egger	3.88888769100368	3	0.273714916410517
GCST90200060	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-(1-enyl-palmitoyl)-2-linoleoyl-GPC (p-16:0/18:2) levels	Inverse variance weighted	9.86076131526265e-32	2	1
GCST90200063	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-palmitoyl-2-docosahexaenoyl-GPE (16:0/22:6) levels	Inverse variance weighted	9.86076131526265e-32	2	1
GCST90200064	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	N-palmitoyl-sphinganine (d18:0/16:0) levels	Inverse variance weighted	3.94430452610506e-31	2	1
GCST90200065	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-stearoyl-2-docosahexaenoyl-GPE (18:0/22:6) levels	Inverse variance weighted	9.86076131526265e-32	2	1
GCST90200070	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1) levels	Inverse variance weighted	3.94430452610506e-31	2	1
GCST90200077	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-stearoyl-2-oleoyl-GPI (18:0/18:1) levels	Inverse variance weighted	2.31318976140797	3	0.509998809256407
GCST90200077	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-stearoyl-2-oleoyl-GPI (18:0/18:1) levels	MR Egger	6.16297582203915e-33	2	1
GCST90200081	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-oleoyl-2-docosahexaenoyl-GPC (18:1/22:6) levels	Inverse variance weighted	9.86076131526265e-32	2	1
GCST90200082	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-oleoyl-2-linoleoyl-GPE (18:1/18:2) levels	Inverse variance weighted	3.94430452610506e-31	2	1
GCST90200103	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1] levels	Inverse variance weighted	3.94430452610506e-31	2	1
GCST90200124	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Sphingomyelin (d18:2/24:2) levels	Inverse variance weighted	9.86076131526265e-32	2	1
GCST90200139	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Dihomo-linolenoylcarnitine (C20:3n3 or 6) levels	Inverse variance weighted	0.194091329274721	2	0.907514563863599
GCST90200139	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Dihomo-linolenoylcarnitine (C20:3n3 or 6) levels	MR Egger	1.97215226305253e-31	1	1
GCST90200243	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Hydroxypalmitoyl sphingomyelin (d18:1/16:0(OH)) levels	Inverse variance weighted	9.86076131526265e-32	2	1
GCST90200266	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Cis-3,4-methyleneheptanoylcarnitine levels	Inverse variance weighted	0.097443693024537	2	0.952446019038922
GCST90200266	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Cis-3,4-methyleneheptanoylcarnitine levels	MR Egger	4.93038065763132e-32	1	1
GCST90200302	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Alpha-tocopherol levels	Inverse variance weighted	3.94430452610506e-31	2	1
GCST90200331	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-palmitoyl-2-oleoyl-GPE (16:0/18:1) levels	Inverse variance weighted	3.94430452610506e-31	2	1
GCST90200336	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Ceramide (d18:1/16:0) levels	Inverse variance weighted	9.86076131526265e-32	2	1
GCST90200341	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	N-stearoyl-sphingosine (d18:1/18:0) levels	Inverse variance weighted	9.86076131526265e-32	2	1
GCST90200485	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	X-12100 levels	Inverse variance weighted	3.68048195029438	3	0.298097495689177
GCST90200485	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	X-12100 levels	MR Egger	3.62538683362911	2	0.163213941080265
GCST90200562	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	X-21286 levels	Inverse variance weighted	0.688711253695707	2	0.708676858713445
GCST90200562	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	X-21286 levels	MR Egger	3.08148791101958e-33	1	1
GCST90200587	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	X-21733 levels	Inverse variance weighted	0.28645508529062	2	0.866556867818497
GCST90200587	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	X-21733 levels	MR Egger	3.08148791101958e-33	1	1
GCST90200685	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-stearoyl-2-arachidonoyl-gpc (18:0/20:4) levels	Inverse variance weighted	2.6286836912278	3	0.452483101258963
GCST90200685	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-stearoyl-2-arachidonoyl-gpc (18:0/20:4) levels	MR Egger	2.46519032881566e-32	2	1
GCST90200692	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	1-palmitoyl-2-arachidonoyl-gpc (16:0/20:4n6) levels	Inverse variance weighted	3.94430452610506e-31	2	1
GCST90200708	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	X-12112 levels	Inverse variance weighted	2.08960905916647	3	0.554017780190661
GCST90200708	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	X-12112 levels	MR Egger	1.96476810325264	2	0.374417403546971
GCST90200794	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Oleoyl-linoleoyl-glycerol (18:1 to 18:2) [2] to linoleoyl-arachidonoyl-glycerol (18:2 to 20:4) [1] ratio	Inverse variance weighted	3.94430452610506e-31	2	1
GCST90200795	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Oleoyl-linoleoyl-glycerol (18:1 to 18:2) [2] to linoleoyl-arachidonoyl-glycerol (18:2 to 20:4) [2] ratio	Inverse variance weighted	3.94430452610506e-31	2	1
GCST90200801	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	5-methylthioadenosine (MTA) to phosphate ratio	Inverse variance weighted	1.70495801438138	2	0.426356679508677
GCST90200801	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	5-methylthioadenosine (MTA) to phosphate ratio	MR Egger	1.97215226305253e-31	1	1
GCST90200810	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Alpha-ketoglutarate to kynurenine ratio	Inverse variance weighted	1.45757105709401	2	0.482494610339165
GCST90200810	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Alpha-ketoglutarate to kynurenine ratio	MR Egger	0.16144071983488	1	0.687833530357126
GCST90200900	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Phosphate to oleoyl-linoleoyl-glycerol (18:1 to 18:2) [2] ratio	Inverse variance weighted	3.94430452610506e-31	2	1
GCST90200904	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Phosphate to linoleoyl-arachidonoyl-glycerol (18:2 to 20:4) [1] ratio	Inverse variance weighted	3.94430452610506e-31	2	1
GCST90200907	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Retinol (Vitamin A) to linoleoyl-arachidonoyl-glycerol (18:2 to 20:4) [1] ratio	Inverse variance weighted	3.94430452610506e-31	2	1
GCST90200908	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Retinol (Vitamin A) to linoleoyl-arachidonoyl-glycerol (18:2 to 20:4) [2] ratio	Inverse variance weighted	3.94430452610506e-31	2	1
GCST90200910	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Retinol (Vitamin A) to oleoyl-linoleoyl-glycerol (18:1 to 18:2) [2] ratio	Inverse variance weighted	0.0766244369422628	3	0.994486741435867
GCST90200910	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Retinol (Vitamin A) to oleoyl-linoleoyl-glycerol (18:1 to 18:2) [2] ratio	MR Egger	2.46519032881566e-32	2	1
GCST90200987	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Benzoate to oleoyl-linoleoyl-glycerol (18:1 to 18:2) [2] ratio	Inverse variance weighted	3.94430452610506e-31	2	1
GCST90201003	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Glucose to N-palmitoyl-sphingosine (d18:1 to 16:0) ratio	Inverse variance weighted	1.09649684868946	3	0.777919824934793
GCST90201003	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Glucose to N-palmitoyl-sphingosine (d18:1 to 16:0) ratio	MR Egger	0	2	1
GCST90201004	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Glucose to N-stearoyl-sphingosine (d18:1 to 18:0) ratio	Inverse variance weighted	3.94430452610506e-31	2	1
GCST90201007	ebi-a-GCST90020053	Frailty index || id:ebi-a-GCST90020053	Glucose to N-palmitoyl-sphinganine (d18:0 to 16:0) ratio	Inverse variance weighted	9.86076131526265e-32	2	1
